QRxPharma raises $25m from local, US and UK funds
Anthony MacdonaldColumnist
Updated
QRxPharma, Genetic Technologies and Crusader Resources featured in capital raising news on Friday.
■ QRxPharma raised $25 million in a placement to Australian, US and UK-based fund managers. The company also launched a one-for-20 non-renounceable rights issue to raise another $10.4 million. RBS Morgans and Bell Potter led the deal.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Companies
Fetching latest articles